Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

NCT04736472 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT04736472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04736472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2021
Completion date
October 9, 2024
Enrollment
552 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer